Neonatal Genetics

New-born screening is a screening in infants shortly after birth for a list of conditions that are treatable, but not clinically evident in the new-born period. Some of the conditions included in new-born screening programs are only detectable after irreversible damage has been done, in some cases sudden death is the first manifestation of a disease. Screening programs are often run by state or national governing bodies with the goal of screening all infants born in the jurisdiction.

New-born screening originated with an amino acid disorderphenylketonuria (PKU), which can be easily treated by dietary modifications, but causes severe mental retardation if not identified and treated early.

  • Neonatal cellular bioenergetics
  • Neonatal pharmacokinetics
  • Neonatal screening
  • Fetal origins of adult disease
  • Maternal obesity

Related Conference of Neonatal Genetics

March 28-29, 2024

23rd Annual World Congress on Neonatology

Dubai, UAE
May 23-24, 2024

37th World Pediatrics Conference

Zurich, Switzerland
May 27-28, 2024

36th European Pediatrics Congress

Amsterdam, Netherlands
June 13-14, 2024

3rd World Pediatric Conference

Rome, Italy
June 13-14, 2024

22nd World Congress on Clinical Pediatrics

Rome, Italy
June 13-14, 2024

32nd World Congress on Clinical Pediatrics

Rome, Italy
June 19-20, 2024

9th Annual Summit on Pediatric Cardiology

Rome, Italy
July 18-19, 2024

35th European Pediatrics Conference

Paris, France
August 19-20, 2024

25th Annual World Congress on Pediatrics

Zurich, Switzerland
September 05-06, 2024

24th World Congress on Pediatric Neurology and Neuropathology

Brussels, Belgium
September 16-17, 2024

7th World Pediatric Infectious Disease Congress

Zurich, Switzerland
September 19-20, 2024

25th World Congress on Pediatric Oncology and Cancer Care

Paris, France
September 19-20, 2024

3rd International Conference on Neonatology

Paris, France

Neonatal Genetics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in